Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases
about
UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4'-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers.Use of carvedilol in hypertension: an update.Investigation of carvedilol-evoked Ca²+ movement and death in human oral cancer cells.Tempol prevents cardiac oxidative damage and left ventricular dysfunction in the PPAR-α KO mouse
P2860
Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@ast
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@en
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@nl
type
label
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@ast
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@en
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@nl
prefLabel
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@ast
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@en
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@nl
P2860
P1476
Clinical updates on carvedilol ...... ent of cardiovascular diseases
@en
P2093
Sanjay Singh
Subhashis Chakraborty
P2860
P304
P356
10.1517/17425250903540220
P407
P577
2010-02-01T00:00:00Z